EN
English✓简体中文繁體中文TürkçeEspañolBahasa MelayuBahasa IndonesiaTiếng ViệtPortuguêsРусский

Only complete language versions are shown.

Let’s talk

How to Verify Research Status and Arrangements for Travel to China After Seeing Regenerative Medicine Advertising

EastMedGo

If you receive advertising for “cell repair” or “regenerative treatment,” do not rush to pay a deposit or book flights. Ask the provider to put in writing the exact product or technology, whether it is offered in China through a clinical research or clinical care pathway, and the hospital and department that will actually receive you. Then take the documents to a specialist who treats your underlying condition and has no financial ties to the seller for an independent review.

Key points

  • “Regenerative medicine” covers different products and procedures. A hospital license, patent, trial registration, or ethics approval alone does not prove that an intervention is approved for clinical treatment or guarantee that it works.
  • If the provider says it is research, check the project, hospital, ethics review, and current recruitment status. A registration does not mean recruitment is open, or that you have been enrolled. The research team must confirm your screening results.
  • China has explicit restrictions on applicable research-related charges. If you are asked to pay for a research product, enrollment, or research tests, first request a written explanation and verify it with the hospital’s research administration department and ethics committee. Do not simply accept research charges as a “package fee.”
  • Do not pay or travel until you know how acute complications will be managed and who will take over your care during follow-up and after withdrawal. Your treating doctor should decide whether to adjust your existing treatment.

First, identify what will enter your body

Ask the doctor or research team to provide a written explanation of: the exact product or technology name; the condition it is intended for and the expected improvement; whether it contains living cells, whether the cells come from you or another person, where they are collected from, and how they are processed; and the dose, administration site, number of administrations, and accompanying procedures. If it is described as “cell-free,” ask for its exact ingredients and their sources. PRP (platelet-rich plasma), cells, exosomes, and implant materials are different things. Regulatory status and evidence for one cannot be applied to another.

Also request details of the manufacturer or preparation facility, batch, storage, and quality records for batch release. Ask what identity, contamination, and activity tests are performed; the specific testing requirements depend on the product. Check that the information provided, informed consent form, label, and actual procedure records all refer to the same product and dose. A brochure saying “quality control passed” cannot replace records for the specific batch. If documents cannot be given to patients, ask the hospital to explain what you may review and keep its response.

Check whether it is research or clinical care in China

First ask the provider to state which pathway applies, then verify it using the corresponding documents. The same certificate cannot establish compliance across different pathways:

What the provider says What to request and check What else to confirm
An approved medicine or registered medical device Chinese drug approval information and current prescribing information, or the device registration certificate and intended scope of use Whether the product name, manufacturer, condition, use, and procedure match. For use outside the approved instructions, ask the doctor to explain the clinical evidence, hospital procedures, and consent process.
A new biomedical technology for clinical application The applicable approval documents for clinical translation and application, the approved scope, and requirements for the institutions performing it Whether the specific technology, condition, and hospital fall within the approved scope.
A clinical trial for drug registration Trial registration number, full project name, sponsor, research hospital, research team contact details, and informed consent form Check the protocol and participating sites against the registration, then ask that hospital’s research team to confirm current recruitment, whether it accepts patients from outside China, and the documents needed for preliminary screening.
Other clinical research at a medical institution Project name and number, project authorization and applicable filing information from the hospital’s research administration department, ethics review documents, and informed consent form Check that the project, hospital conducting it, intervention, and condition match, and ask that site directly about current recruitment and screening arrangements.

The Regulations on the Administration of Clinical Research and Clinical Translation and Application of New Biomedical Technologies, effective May 1, 2026, require technologies within their scope to undergo review and approval by the health authority under the State Council before clinical translation and application following completion of research. Medicines and medical devices have their own regulatory pathways. Not all “regenerative” projects belong in the same category. Research registration, institutional filing, and ethics approval each serve different purposes; none is equivalent to approval for clinical application. A hospital’s license to practice also does not mean that every product or use it offers is approved.

Send the project number and documents to the relevant department or research administration office listed on the hospital’s official website for verification. Do not rely only on screenshots forwarded by an intermediary. You can ask: “Does this number correspond to the same intervention, condition, and your hospital? Is your site currently recruiting, and who handles preliminary screening?” If you cannot find a record, the documents do not match, or the hospital cannot confirm the information, pause payment and travel. These findings alone do not establish that the activity is illegal; you can verify its status with the local health authority or other relevant authority.

Compare the advertising with the evidence

Ask the provider for the full studies supporting the proposed use, rather than relying only on patient testimonials or promotional videos. Review them with a specialist who treats your underlying condition: did the studies use the same product, preparation method, and route of administration, and were the patients’ diagnoses and disease duration similar to yours? Check how many people participated, whether there was a comparison group, how long follow-up lasted, how many people withdrew, and whether serious adverse events and poor outcomes were reported.

Turn promises into specific questions: “Is the aim to improve pain, walking, or daily activities, or to slow the disease? How will improvement be measured, how large might it be, and how long might it last?” Changes on imaging, laboratory results, and improvements that patients actually feel or experience in their functioning are different outcomes. MRI changes alone cannot confirm that new, functioning tissue has grown. Laboratory or animal studies, patents, and a hospital’s reputation also cannot prove that the procedure will work for you.

Ask the doctor to explain current standard treatments, the consequences of waiting or not participating, and circumstances in which the intervention may be unsuitable, must be stopped, or cannot be repeated. Ask whether the team, doctors, intermediary, and product company have referral fees, commissions, equity interests, or other financial ties. If you encounter claims such as “cures all diseases” or “completely safe,” pressure to pay by a deadline, or refusal to provide documents, pause your decision and seek verification from an independent doctor.

Clarify risks, costs, and withdrawal before applying

Risks and emergency care. Ask the doctor performing the intervention to explain the risks of the specific product, route of administration, and procedure, including infection, bleeding, and immune reactions. Risks vary by product and treatment site. The US FDA has received reports of blindness, infections, and tumor formation associated with some unapproved products. These reports cannot establish how likely these events are with a particular product or replace an assessment of its approval status in China. Ask which hospital will treat a serious reaction, who will arrange contact and cover the costs, and whether the intervention could affect your eligibility for later surgery, transplantation, or trials. If you suddenly develop severe symptoms such as difficulty breathing, altered consciousness, or heavy bleeding, contact local emergency services immediately. For other new or worsening symptoms, contact the team that performed the intervention and your local care team promptly. If you cannot reach them or symptoms worsen rapidly, seek emergency care without delay. Tell the clinicians what product you received, when it was given, and how it was administered.

Costs. For clinical care, ask the hospital for a written estimate itemizing tests, products, procedures, hospitalization, complications, rehabilitation, and follow-up. List interpretation, intermediary fees, flights, accommodation, visas, and accompanying care separately. Ask your insurer whether it will confirm coverage in writing for that hospital and the specific use, and which costs you must pay upfront. For research, first confirm the applicable pathway and charging rules: China’s Measures for the Ethical Review of Life Science and Medical Research Involving Humans prohibit charging participants research-related fees. Corresponding rules also apply to clinical research on new biomedical technologies within their scope. In drug clinical trials, sponsors and trial institutions must not charge participants fees related to the trial; sponsors must also provide trial medicines free of charge and pay for related medical tests. Applicable research ethics rules require appropriate compensation for reasonable expenses incurred through participation. Ask the research team to explain in writing who pays for routine care, whether travel and accommodation count as reasonable expenses eligible for compensation, what receipts or other documentation are required, and how to apply. Do not assume all travel expenses will be reimbursed. If you are unsure how a charge is classified, verify it with the hospital’s research administration department and ethics committee.

Withdrawal and refunds. Obtain a copy of the informed consent form before joining research. Ask who receives withdrawal notices, what safety checks are needed after the intervention stops, how existing data or samples will be handled, and who will take over your care afterward. Applicable Chinese research ethics rules allow participants to withdraw unconditionally at any stage. Withdrawal does not mean that procedures already performed can be reversed. For paid services outside research, agree separately on refunds or deductions, who handles them, and the deadlines if screening is unsuccessful, preparation fails, the doctor cancels, your condition changes, or you cancel. Do not assume every deposit is refundable.

Harm and follow-up. Request the arrangements for managing and compensating research-related harm. Confirm emergency contacts, how care away from the research site will be coordinated, and who is responsible for costs. Applicable research ethics rules require timely, free treatment for participants who suffer research-related harm, as well as compensation or damages in accordance with the law and the agreement between the parties. Responsibility for treatment costs arising from health damage caused by clinical research on new biomedical technologies must also be checked against the regulations and the specific circumstances. Ask how long follow-up is needed, how often checkups are required, who takes over if contact is lost or the team changes, and which safety follow-up visits are still recommended after withdrawal.

Confirm hospital acceptance and care after returning home before traveling to China

Prepare the materials requested by the hospital, such as your diagnosis and pathology records, original imaging files and reports, previous treatments and medicines, allergies and complications, recent tests, and name as shown on your passport. First ask which formats and languages the hospital accepts, then submit the materials through its designated secure channel. Do not send complete identity documents or medical records in public group chats.

Get a written response from the hospital before arranging travel. Confirm the actual hospital campus, department, research team or treating doctor, appointment time, screening steps, whether patients from outside China are accepted, and interpretation arrangements. Passing preliminary screening, securing an appointment, and formal enrollment are different stages. Tests after arrival may still show that you do not qualify for enrollment. Ask about the expected length of your stay in China, repeat tests, possible extensions or rescheduling, and the budget. Confirm visa and insurance conditions separately with the relevant authority and insurer.

Before leaving the hospital, request medical and procedure records: product name, source, dose, batch, administration date and site, medicines and anesthesia, test results, adverse events, discharge summary, and follow-up plan. Keep a batch quality-control summary if one is available. Ask the team to put in writing whom to contact about problems, when your next checkup is due, and which documents can be shared with your next care team. Before returning home, confirm with the doctor who will receive you locally whether they can accept the records, who should receive follow-up results, and where you should seek care if problems arise. If the handover is not yet arranged, first contact both teams to coordinate it.

Frequently asked questions

Is PRP the same as stem cell treatment?

No. PRP is a blood preparation with a relatively high concentration of platelets. Its specific preparation method, uses, and evidence must be checked separately.

Is it always safe if my own cells are used, or if the product contains no living cells?

You cannot judge safety on that basis. Risks involving collection, processing, contamination, administration, and immune reactions still need to be assessed for the specific product. “Autologous” or “cell-free” cannot replace evidence of quality and safety.

If a hospital says it has ethics approval, does that mean the treatment is approved?

No. Ethics review addresses research participants’ rights and interests and the research protocol. It is not equivalent to approval to market a product or use a technology in clinical care. Check the full project, applicable pathway, and actual participating site.

If the registration page says recruitment is open, do I still need to ask the hospital?

Yes. Registration information may be out of date, and a particular site or study group may already be full or paused. Ask the actual hospital to confirm its current status and screening criteria. Final enrollment depends on the research team’s assessment.

If an approved product is used outside its approved instructions, can I immediately determine whether that is legal?

That fact alone is not enough to decide. Ask the doctor to show the product’s Chinese approval and prescribing information or instructions, and explain the evidence for that use, hospital procedures, and informed consent. If necessary, verify this with the hospital’s medical affairs department.

What if the research provider says, “The product is free; we only charge an enrollment service fee”?

Request a written list identifying who is charging and what each service covers. First verify the nature of the charges and the applicable rules with the hospital’s research administration department and ethics committee. Do not assume a charge is unrelated to research simply because it has a different name.

What happens if I fail screening or the cells cannot be prepared successfully?

Before paying or undergoing collection, confirm who will explain the reason, who will continue treatment for your underlying condition, and how charges already incurred for services outside research and any refunds will be handled. Do not stop your existing treatment on your own.

What if I have already paid or undergone a procedure, but my documents are incomplete?

Keep contracts, invoices, chat records, and product packaging. Request medical records and product and batch information from the hospital in writing. If you feel unwell, seek medical care first. If you have questions about charges or qualifications, you can raise them with the hospital’s medical affairs or research administration department, the local health authority, and other relevant authorities.

Sources

The sources below were checked on November 6, 2026. Specific projects, approvals, and recruitment status may change and should be verified again with the relevant authorities and the actual hospital.

Chat on WhatsAppEmail